• Emergence of a hematopoietic stem cell hierarchy and self-renewal concept, contrasting primitive stem cells with differentiating progenitors through in vivo serial transplantation and ex vivo colony assays, revealing two functional compartments. [7] [12]

• Development and standardization of transplantation potency readouts, combining fresh/stored marrow assays and CFU recovery metrics to compare donor material across in vivo and in vitro systems. [4] [15] [6]

• Irradiation-driven engraftment dynamics and host conditioning shaped reconstitution: CFU restoration timelines, isogenic chimeras, and protective effects of donor hematopoietic cells. [2] [8] [6] [9]

• Immunology-focused strategies to enable transplantation, including selective depletion of immunologically competent cells, anti-lymphocyte serum effects, and thymus/marrow graft immunoreconstitution. [13] [19] [11] [17]

• Clinical translation efforts emphasizing infant transplantation and Wiskott-Aldrich syndrome, illustrating early therapeutic transplantation in humans and associated immunologic considerations. [17] [18] [14]